Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002264811 | SCV002546463 | likely benign | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2022-04-25 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.249C>T (p.Ala83=) is a synonymous variant. REVEL score not calculable. SpliceAI predicts: Acceptor loss 0.00, Donor loss 0.00, Acceptor gain 0.00, Donor gain 0.00. (BP4) Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score 0.324528 < 2.0 or the variant is the reference nucleotide in one primate and/or three mammal species) (BP7). PM2_supporting: This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7, PM2_supporting. |
Labcorp Genetics |
RCV001494590 | SCV001699250 | likely benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2023-02-20 | criteria provided, single submitter | clinical testing |